Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen

A major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostat...

Full description

Bibliographic Details
Main Authors: Laura Cid-Barrio, Jorge Ruiz Encinar, José Manuel Costa-Fernández
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/20/18/5287
id doaj-83921677d4dc48c9807d4260f8e84e1c
record_format Article
spelling doaj-83921677d4dc48c9807d4260f8e84e1c2020-11-25T03:28:47ZengMDPI AGSensors1424-82202020-09-01205287528710.3390/s20185287Catalytic Gold Deposition for Ultrasensitive of Prostate Specific AntigenLaura Cid-Barrio0Jorge Ruiz Encinar1José Manuel Costa-Fernández2Department of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainDepartment of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainDepartment of Physical and Analytical Chemistry, University of Oviedo, Av. Julián Clavería 8, 33006 Oviedo, SpainA major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostate-specific antigen (PSA), a well-recognized cancer biomarker. A sandwich type immunosensor has been developed employing a detection antibody labeled with inorganic nanoparticles acting as tags for further indirect quantification of the analyte. The required high sensitivity is then achieved through a controlled gold deposition on the nanoparticle surface, carried out after completing the recognition step of the immunoassay, thus effectively amplifying the size of the nanoparticles from nm to µm range. Due to such an amplification procedure, quantification of the biomolecule could be carried out directly on the immunoassay plates using confocal microscopy for measurement of the reflected light produced by gold-enlarged nanostructures. The high specificity of the immunoassay was demonstrated with the addition of a major abundant protein in serum (albumin) at much higher concentrations. An extremely low detection limit for PSA quantification (LOD of 1.1 fg·mL<sup>−1</sup> PSA) has been achieved. Such excellent LOD is 2–3 orders of magnitude lower than the clinically relevant PSA levels present in biological samples (4–10 ng·mL<sup>−1</sup>) and even to monitor eventual recurrence after clinical treatment of a prostate tumor (0.1 ng·mL<sup>−1</sup>). In fact, the broad dynamic range obtained (4 orders of magnitude) would allow the PSA quantification of diverse samples at very different relevant levels.https://www.mdpi.com/1424-8220/20/18/5287quantum dotsimmunoassaybiomarkernanotechnologysignal amplification
collection DOAJ
language English
format Article
sources DOAJ
author Laura Cid-Barrio
Jorge Ruiz Encinar
José Manuel Costa-Fernández
spellingShingle Laura Cid-Barrio
Jorge Ruiz Encinar
José Manuel Costa-Fernández
Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
Sensors
quantum dots
immunoassay
biomarker
nanotechnology
signal amplification
author_facet Laura Cid-Barrio
Jorge Ruiz Encinar
José Manuel Costa-Fernández
author_sort Laura Cid-Barrio
title Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
title_short Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
title_full Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
title_fullStr Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
title_full_unstemmed Catalytic Gold Deposition for Ultrasensitive of Prostate Specific Antigen
title_sort catalytic gold deposition for ultrasensitive of prostate specific antigen
publisher MDPI AG
series Sensors
issn 1424-8220
publishDate 2020-09-01
description A major challenge in the development of bioanalytical methods is to achieve a rapid and robust quantification of disease biomarkers present at very low concentration levels in complex biological samples. An immunoassay platform is presented herein for ultrasensitive and fast detection of the prostate-specific antigen (PSA), a well-recognized cancer biomarker. A sandwich type immunosensor has been developed employing a detection antibody labeled with inorganic nanoparticles acting as tags for further indirect quantification of the analyte. The required high sensitivity is then achieved through a controlled gold deposition on the nanoparticle surface, carried out after completing the recognition step of the immunoassay, thus effectively amplifying the size of the nanoparticles from nm to µm range. Due to such an amplification procedure, quantification of the biomolecule could be carried out directly on the immunoassay plates using confocal microscopy for measurement of the reflected light produced by gold-enlarged nanostructures. The high specificity of the immunoassay was demonstrated with the addition of a major abundant protein in serum (albumin) at much higher concentrations. An extremely low detection limit for PSA quantification (LOD of 1.1 fg·mL<sup>−1</sup> PSA) has been achieved. Such excellent LOD is 2–3 orders of magnitude lower than the clinically relevant PSA levels present in biological samples (4–10 ng·mL<sup>−1</sup>) and even to monitor eventual recurrence after clinical treatment of a prostate tumor (0.1 ng·mL<sup>−1</sup>). In fact, the broad dynamic range obtained (4 orders of magnitude) would allow the PSA quantification of diverse samples at very different relevant levels.
topic quantum dots
immunoassay
biomarker
nanotechnology
signal amplification
url https://www.mdpi.com/1424-8220/20/18/5287
work_keys_str_mv AT lauracidbarrio catalyticgolddepositionforultrasensitiveofprostatespecificantigen
AT jorgeruizencinar catalyticgolddepositionforultrasensitiveofprostatespecificantigen
AT josemanuelcostafernandez catalyticgolddepositionforultrasensitiveofprostatespecificantigen
_version_ 1724582772323909632